{"id":482833,"title":"Guidance Document: Considerations for Inclusion of Women in Clinical Trials and Analysis of Sex Differences - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T20:01:52.564000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/considerations-inclusion-women-clinical-trials.html?wbdisable=true","snippet":"Guidance Document: Considerations for Inclusion of Women in Clinical Trials and Analysis of Sex Differences Date 05/29/2013 Foreword Guidance documents are meant to provide assistance to industry and health care professionals on how to comply with governing statutes and…","rawSnapshotUrl":"/api/snapshots/raw/482833","browseUrl":"https://replay.healtharchive.ca/job-6/20260106200152/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/considerations-inclusion-women-clinical-trials.html?wbdisable=true#ha_snapshot=482833","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}